Overview
Ring chromosome 13 syndrome (also known as r(13) syndrome) is a rare chromosomal disorder in which both ends of chromosome 13 are deleted and the remaining chromosome forms a ring structure. The clinical presentation is highly variable and depends on the amount of genetic material lost during ring formation. The condition affects multiple body systems, most notably the nervous system, musculoskeletal system, and craniofacial structures. Common features include intellectual disability of variable severity, microcephaly, facial dysmorphism (including a prominent nasal bridge, thin upper lip, and large or low-set ears), short stature, and genital anomalies in males (such as hypospadias or ambiguous genitalia). Retinoblastoma may occur in cases where the RB1 gene on chromosome 13q14 is deleted as part of the ring formation. Additional clinical features can include limb anomalies such as thumb hypoplasia or aplasia, foot abnormalities, and overlapping toes. Some patients may present with congenital heart defects, anal atresia, or eye abnormalities. Growth retardation is frequently observed both prenatally and postnatally. The degree of intellectual disability ranges from mild to severe and correlates with the extent of chromosomal material lost. Ring chromosome instability during cell division can lead to mosaicism, with some cells losing the ring chromosome entirely (monosomy 13) or duplicating it, which further contributes to phenotypic variability. There is no cure for ring chromosome 13 syndrome, and management is supportive and symptom-based. Treatment may include early intervention programs, speech and occupational therapy, surgical correction of congenital anomalies (such as cardiac defects or anal atresia), and regular ophthalmologic screening for retinoblastoma when the RB1 locus is deleted. Genetic counseling is recommended for affected families. Long-term follow-up with a multidisciplinary team including geneticists, neurologists, cardiologists, and developmental specialists is essential for optimizing outcomes.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Ring chromosome 13 syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ring chromosome 13 syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Ring chromosome 13 syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ring chromosome 13 syndrome.
Community
No community posts yet. Be the first to share your experience with Ring chromosome 13 syndrome.
Start the conversation →Latest news about Ring chromosome 13 syndrome
No recent news articles for Ring chromosome 13 syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Ring chromosome 13 syndrome
What is Ring chromosome 13 syndrome?
Ring chromosome 13 syndrome (also known as r(13) syndrome) is a rare chromosomal disorder in which both ends of chromosome 13 are deleted and the remaining chromosome forms a ring structure. The clinical presentation is highly variable and depends on the amount of genetic material lost during ring formation. The condition affects multiple body systems, most notably the nervous system, musculoskeletal system, and craniofacial structures. Common features include intellectual disability of variable severity, microcephaly, facial dysmorphism (including a prominent nasal bridge, thin upper lip, and
How is Ring chromosome 13 syndrome inherited?
Ring chromosome 13 syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Ring chromosome 13 syndrome typically begin?
Typical onset of Ring chromosome 13 syndrome is neonatal. Age of onset can vary across affected individuals.